Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Depreciation & Amortization (CF) (2016 - 2021)

Historic Depreciation & Amortization (CF) for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q4 2021 value amounting to $20000.0.

  • Phio Pharmaceuticals' Depreciation & Amortization (CF) rose 1764.71% to $20000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $75000.0, marking a year-over-year increase of 416.67%. This contributed to the annual value of $2000.0 for FY2024, which is 9642.86% down from last year.
  • Per Phio Pharmaceuticals' latest filing, its Depreciation & Amortization (CF) stood at $20000.0 for Q4 2021, which was up 1764.71% from $19000.0 recorded in Q3 2021.
  • Phio Pharmaceuticals' Depreciation & Amortization (CF)'s 5-year high stood at $22000.0 during Q4 2017, with a 5-year trough of $11000.0 in Q1 2017.
  • In the last 5 years, Phio Pharmaceuticals' Depreciation & Amortization (CF) had a median value of $18000.0 in 2019 and averaged $18250.0.
  • In the last 5 years, Phio Pharmaceuticals' Depreciation & Amortization (CF) skyrocketed by 8333.33% in 2017 and then tumbled by 2500.0% in 2019.
  • Over the past 5 years, Phio Pharmaceuticals' Depreciation & Amortization (CF) (Quarter) stood at $22000.0 in 2017, then dropped by 9.09% to $20000.0 in 2018, then dropped by 20.0% to $16000.0 in 2019, then rose by 6.25% to $17000.0 in 2020, then rose by 17.65% to $20000.0 in 2021.
  • Its last three reported values are $20000.0 in Q4 2021, $19000.0 for Q3 2021, and $18000.0 during Q2 2021.